BIOMAT Database Logo BIOMAT Database Logo

Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. 1981

P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill

UI MeSH Term Description Entries
D008297 Male Males
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001026 Coronary Artery Bypass Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion. Aortocoronary Bypass,Bypass, Coronary Artery,Bypass Surgery, Coronary Artery,Coronary Artery Bypass Grafting,Coronary Artery Bypass Surgery,Aortocoronary Bypasses,Artery Bypass, Coronary,Artery Bypasses, Coronary,Bypass, Aortocoronary,Bypasses, Aortocoronary,Bypasses, Coronary Artery,Coronary Artery Bypasses
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Thrombogenicity of pulmonary-artery catheters.
January 1987, Intensive care medicine,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?
August 1999, Journal of cardiothoracic and vascular anesthesia,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Thrombogenicity of heparin- and non-heparin-coated catheters: clinical trail.
November 1982, AJR. American journal of roentgenology,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Introducers and protective sleeves may increase thrombogenicity of pulmonary artery catheters.
April 1999, Journal of cardiothoracic and vascular anesthesia,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Heparin-induced thrombocytopenia: a possible complication of heparin-coated pulmonary artery catheters.
April 1990, Journal of cardiothoracic anesthesia,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Early Thrombosis and Non-Heparin-Coated Pulmonary Artery Catheters.
August 2017, Journal of cardiothoracic and vascular anesthesia,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Fan-shaped shadows due to pulmonary artery catheters: heparin prophylaxis.
October 1977, British medical journal,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
March 2006, Journal of vascular surgery,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Thrombogenicity of angiographic catheters.
September 1978, Circulation research,
P F Hoar, and R M Wilson, and D T Mangano, and G J Avery, and R J Szarnicki, and J D Hill
Effect of heparin-bonded pulmonary artery catheters on the activated coagulation time.
October 1998, Journal of cardiothoracic and vascular anesthesia,
Copied contents to your clipboard!